Bullosis diabeticorum (BD), although a rare manifestation, is characteristic of diabetes mellitus. The exact origin of BD is unknown. We report another case of a 54-year-old man who developed a blistering lesion on his left leg. Histopathological examination revealed a microangiopathy with hyalinosis of the blood vessel walls.

Keywords:
Bullosis diabeticorum, Diabetes mellitus
1.
Kramer DW: Early warning signs of impending gangrene in diabetes mellitus. Med J Rec 1930;132:338–342.
2.
Cantwell AR, Martz W: Idiopathic bullae in diabetics. Arch Dermatol 1967;96:42–44.
3.
Collet JT, Toonstra J: Bullosis diabeticorum: A case with lesions restricted to the hands. Diabetes Care 1985;8:177–179.
4.
Toonstra J: Bullosis diabeticorum: Report of a case with review of literature. J Am Acad Dermatol 1985;13:799–805.
5.
Perez MJ, Kohn SR: Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1994;30:519–531.
6.
Basarab T, Munn SE, McGrath J, Russell Jones R: Bullosis diabeticorum: A case report and literature review. Clin Exp Dermatol 1995;20:218–220.
7.
Bernstein JE, Levine LE, Medenica M: Reduced threshold to suction-induced blister formation in insulin-dependent diabetics. J Am Acad Dermatol 1983;8:790–791.
8.
Bernstein JE, Medenica M, Soltani K: Bullous eruption of diabetes mellitus. Arch Dermatol 1979;116:324–325.
9.
James WD, Odom RB, Goette DK: Bullous eruption of diabetes mellitus: A case with positive immunofluorescence microscopy findings. Arch Dermatol 1979;115:324–325.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.